Centene enters New York in a new $3.85BN agreement with Fidelis Care

By Catherine Sturman
Share
Multinational healthcare company Centene Corp is expanding into new markets, and is set to enter New York in a new deal with non-profit health insurer F...

Multinational healthcare company Centene Corp is expanding into new markets, and is set to enter New York in a new deal with non-profit health insurer Fidelis Care.

As a result of New York’s rulings surrounding the acquisition of non-profit companies, the deal is being regarded as an asset purchase, with Fidelis CEO remaining on board. Its current operations will remain standing in the city.

Centene shares rose upon the announcement of the deal, which is set to complete in Q1 in 2018.

At present, Fidelis Care is operational in over 60 states in the US, therefore expanding Centene’s market reach and subsequent membership numbers.

Related stories

Fidelis Care works to provide affordable health insurance coverage for children and adults through Medicaid, Qualified Health Plans, Child Health Plus, Essential Plan, as well as Medicare Advantage, Dual Advantage and Managed Long-Term Care.

We think there is tremendous potential here," said Michael Neidorff, Centene Chairman and CEO. "Centene's and Fidelis Care's missions are fully aligned in terms of promoting health through high quality, accessible care and services for all and advocating for health policy that accords true dignity and respect for all people, especially the underserved."

The company is also set to enter Nevada in 2018, despite continual uncertainties surrounding President Trump’s position surrounding the healthcare sector.

With the addition of New York, Centene will have a leadership position in the country's four largest managed care states by membership – California, Florida, New York and Texas.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma